News Image

DaVita Honors 25 Years of Clinical Advancement in Chronic Disease Care

Provided By PR Newswire

Last update: Aug 27, 2025

Largest kidney care research arm advances science to inform care delivery

DENVER, Aug. 27, 2025 /PRNewswire/ -- As part of its 25th-anniversary celebration, DaVita, a leading provider of comprehensive kidney care, is proud to spotlight the groundbreaking work of its wholly owned research arm, DaVita Clinical Research (DCR). For a quarter-century, DCR has played a pivotal role in advancing kidney care — driving access to new therapies, improving clinical outcomes and shaping the future of nephrology through rigorous research and clinical trials.

Read more at prnewswire.com

DAVITA INC

NYSE:DVA (9/26/2025, 8:04:00 PM)

After market: 130.8 0 (0%)

130.8

+0.53 (+0.41%)



Find more stocks in the Stock Screener

Follow ChartMill for more